We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Novel Cellular Entry Factor for Viral Vectors Used in Gene Therapy

News   Jan 24, 2020 | Original story from Massachusetts Eye and Ear

 
Novel Cellular Entry Factor for Viral Vectors Used in Gene Therapy
 
 
 

RELATED ARTICLES

Link Between Gene and Exercise Capacity

News

In a study published in The New England Journal of Medicine, a research team has found a link between a genetic mutation that affects cellular oxygen sensing and a patient’s limited exercise capacity.

READ MORE

New “Jekyll and Hyde” Immune Cell Discovered

News

Scientists have identified a rare, new cell that plays a key protective role in immunity to infection but – if unregulated – can also mediate tissue damage in autoimmune disorders.

READ MORE

Research Outlines How Drug in Clinical Trial for Coronavirus Works

News

A new study published in the Journal of Biological Chemistry outlines how an antiviral drug that is currently being tested in patients with the novel coronavirus (COVID-19), remdesivir, works.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE